Sodium nitroprusside induces apoptosis of H9C2 cardiac muscle cells in a c-Jun N-terminal kinase-dependent manner.

Sodium nitroprusside (SNP) induces apoptosis in H9C2 cardiac muscle cells. Treatment with an exogenous NO donor SNP (2 mM) to H9C2 cells resulted in apoptotic morphological changes; a bright blue-fluorescent condensed nuclei and chromatin fragmentation by fluorescence microscope of Hoechst 33258-staining. The activity of caspase-3 like protease was increased during SNP-induced cell death. However, the activity of caspase-1 like protease was not affected by SNP. Pretreatment with Z-VAD-FMK (a pan-caspase inhibitor) or Ac-DEVD-CHO (a specific caspase-3 inhibitor) abrogated the SNP-induced cell death. SNP markedly activated three MAP kinases (JNK/SAPK, ERK and p38 MAP kinase) in the cardiac muscle cells. In this study, selective inhibition of the ERK or p38 MAPK pathway (by PD98059 or SB203580, respectively) had no effect on the extent of SNP-induced apoptosis in cardiac muscle cells. In contrast, inhibition of the JNK pathway by transfection of a dominant negative mutant of JNK markedly reduced the extent of SNP-induced cell death. Taken together, we suggest that JNK/SAPK will be related to SNP-induced apoptosis of H9C2 cardiac muscle cells.

[1]  N. Young,et al.  Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha. , 1995, The Journal of clinical investigation.

[2]  G. Cohen,et al.  Caspase Activation Involves the Formation of the Aposome, a Large (∼700 kDa) Caspase-activating Complex* , 1999, The Journal of Biological Chemistry.

[3]  C. Nathan,et al.  Nitric oxide as a secretory product of mammalian cells , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  R. Michler,et al.  Apoptosis of cardiac myocytes during cardiac allograft rejection. Relation to induction of nitric oxide synthase. , 1996, Circulation.

[5]  E. Nishida,et al.  A novel SAPK/JNK kinase, MKK7, stimulated by TNFα and cellular stresses , 1997, The EMBO journal.

[6]  P. Poole‐Wilson,et al.  Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. , 1992, The American journal of physiology.

[7]  J. Douglas,et al.  Nitric oxide production and absorption in trachea, bronchi, bronchioles, and respiratory bronchioles of humans. , 1999, Journal of applied physiology.

[8]  C. Maragos,et al.  Nitric oxide/nucleophile complexes inhibit the in vitro proliferation of A375 melanoma cells via nitric oxide release. , 1993, Cancer research.

[9]  S. Snyder,et al.  Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase , 1991, Nature.

[10]  D. Bredt,et al.  Perspectives Series : Nitric Oxide and Nitric Oxide Synthases Nitric Oxide in Excitable Tissues : Physiological Roles and Disease , 2013 .

[11]  T. Yue,et al.  Staurosporine-induced apoptosis in cardiomyocytes: A potential role of caspase-3. , 1998, Journal of molecular and cellular cardiology.

[12]  P. Cohen,et al.  The activation of distinct mitogen-activated protein kinase cascades is required for the stimulation of 2-deoxyglucose uptake by interleukin-1 and insulin-like growth factor-1 in KB cells. , 1995, The Biochemical journal.

[13]  J. Williamson,et al.  Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase , 1995, The Journal of experimental medicine.

[14]  K. Schappert,et al.  Molecular cloning and characterization of human endothelial nitric oxide synthase , 1992, FEBS letters.

[15]  S. Moncada The 1991 Ulf von Euler Lecture. The L-arginine: nitric oxide pathway. , 1992, Acta physiologica Scandinavica.

[16]  A. Bridges,et al.  A synthetic inhibitor of the mitogen-activated protein kinase cascade. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Simon C Watkins,et al.  Negative inotropic effects of cytokines on the heart mediated by nitric oxide. , 1992, Science.

[18]  K. Guan,et al.  Cloning and characterization of two distinct human extracellular signal-regulated kinase activator kinases, MEK1 and MEK2. , 1993, The Journal of biological chemistry.

[19]  D. Young,et al.  Cloning and Characterization of MEK6, a Novel Member of the Mitogen-activated Protein Kinase Kinase Cascade (*) , 1996, The Journal of Biological Chemistry.

[20]  P. Cannon,et al.  The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor beta. , 1995, The Journal of clinical investigation.

[21]  A. Berdeaux Nitric oxide: an ubiquitous messenger , 1993, Fundamental & clinical pharmacology.

[22]  S. Dimmeler,et al.  Endotoxin-induced changes of endothelial cell viability and permeability: protective effect of a 21-aminosteroid. , 1995, European journal of pharmacology.

[23]  J. Balligand,et al.  Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. , 1993, The Journal of clinical investigation.

[24]  Hyung-Ryong Kim,et al.  Transition Metal Induces Apoptosis in MC3T3E1 Osteoblast: Evidence of Free Radical Release , 2000 .

[25]  R. Michler,et al.  Apoptosis and increased expression of inducible nitric oxide synthase in human allograft rejection. , 1998, Transplantation.

[26]  A. Wardlaw,et al.  A comparative study of different methods for the assessment of apoptosis and necrosis in human eosinophils. , 1998, Journal of immunological methods.

[27]  C. Nathan,et al.  Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells , 1989, The Journal of experimental medicine.

[28]  M. Karin,et al.  JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain , 1994, Cell.

[29]  J. Balligand,et al.  Regulation of cardiac myocyte contractile function by inducible nitric oxide synthase (iNOS): mechanisms of contractile depression by nitric oxide. , 1998, Journal of molecular and cellular cardiology.

[30]  Carl Nathan,et al.  Nitric oxide synthases: Roles, tolls, and controls , 1994, Cell.

[31]  S. Moncada,et al.  The L-arginine-nitric oxide pathway. , 1993, The New England journal of medicine.

[32]  P. Damoulis,et al.  Nitric Oxide Acts in Conjunction with Proinflammatory Cytokines to Promote Cell Death in Osteoblasts , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[33]  M. Mcdaniel,et al.  Aminoguanidine, a Novel Inhibitor of Nitric Oxide Formation, Prevents Diabetic Vascular Dysfunction , 1992, Diabetes.

[34]  A. Laties,et al.  Activation of Caspase-3 in the Retina of Transgenic Rats with the Rhodopsin Mutation S334ter during Photoreceptor Degeneration , 1999, The Journal of Neuroscience.

[35]  O. Feron,et al.  Nitric oxide synthases: which, where, how, and why? , 1997, Journal of Clinical Investigation.

[36]  S. Moncada,et al.  Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.

[37]  K. Baek,et al.  Macrophage nitric oxide synthase subunits. Purification, characterization, and role of prosthetic groups and substrate in regulating their association into a dimeric enzyme. , 1993, The Journal of biological chemistry.

[38]  Michael E. Greenberg,et al.  Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis , 1995, Science.

[39]  D. Zechner,et al.  A Role for the p38 Mitogen-activated Protein Kinase Pathway in Myocardial Cell Growth, Sarcomeric Organization, and Cardiac-specific Gene Expression , 1997, The Journal of cell biology.

[40]  L. Zon,et al.  The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat , 1996, Current Biology.